BioNTech (22UAy.DE) expects results by September from trials testing the COVID-19 vaccine that it and Pfizer (PFE.N) have developed in babies as young as six months old, German magazine Spiegel cited the company’s CEO as saying. “In July, the first…
BioNTech expects vaccine trial results for babies by September
